Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Hansmann, G; Christou, H; Koestenberger, M; Sallmon, H.
Off-label use of PAH-targeted medications approved for adults and their financial coverage by health insurances are vital for children with pulmonary hypertension.
EUR J CLIN INVEST. 2021; 51(8): e13571
Doi: 10.1111/eci.13571
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Koestenberger Martin
- Sallmon Hannes
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Antihypertensive Agents - therapeutic use
- Child - administration & dosage
- Humans - administration & dosage
- Hypertension, Pulmonary - drug therapy
- Insurance, Health - administration & dosage
- Observational Studies as Topic - administration & dosage
- Off-Label Use - administration & dosage
- Randomized Controlled Trials as Topic - administration & dosage
- Find related publications in this database (Keywords)
- children
- macitentan
- off-label
- pulmonary hypertension
- riociguat
- selexipag